GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users. Weight-loss drugs are ...

The demand for highly sought-after weight-loss drugs continues to rise. However, as more patients embrace this trend, doctors are cautioning them about potential side effects. Anti-obesity medications ...

Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file ...

There’s no doubt that GLP-1 drugs like Ozempic have been revolutionary — although the benefits do sometimes come with some unsightly downsides such as tooth decay, a droopy face or mouth, a saggy butt ...

A look at how GLP-1 drugs like Ozempic and Wegovy have changed the culture surrounding weight loss. Trump administration signs minerals deal with Ukraine in key move for Russian peace 41 States That ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Officials ...

Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and ...

The kids are alright — on GLP-1s, that is. A new study found that the blockbuster treatment Mounjaro can dramatically lower blood sugar and body weight in children as young as 10 with Type 2 diabetes.